Exits

Name Description Event Date Acquired Bysort icon
<a href="http://www.exactsciences.com/" target="_blank">EXACT Sciences</a> Proprietary technologies for the early detection, monitoring and staging of common cancers IPO 2001
<a href="/www.evotec.com" target="_blank">Renovis</a> Discovery, development and commercialization of druts to treat neurological diseases and disorders IPO 2004
Seres Therapeutics Developing a novel class of biological drugs that are designed to treat disease by restoring the function of a dysbiotic microbiome. IPO 2015
Editas Medicine Leading genome editing company translating its proprietary technology into novel solutions to treat a broad range of genetically-driven diseases. IPO 2016